Search research articles
Contact Us
Filters
Showing results (81-90 of 109) with videos related to
Page
of 11
Sort By:
Plos One
|
January 9, 2016
Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
Zhi Yon Charles Toh, May Thandar Aung-Htut, Gavin Pinniger, et al.
International Journal of Molecular Sciences
|
October 17, 2019
Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
May T Aung-Htut, Craig S McIntosh, Kristin A Ham, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of <i>SMN2</i> in SMA Type I Fibroblasts
Jarichad Toosaranont, Sukanya Ruschadaariyachat, Warasinee Mujchariyakul, et al.
Journal of Neuroimmunology
|
September 27, 2012
Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis
Arada Rojana-udomsart, Chalermchai Mitrpant, Ian James, et al.
Studies in Health Technology and Informatics
|
July 27, 2015
A Registry Framework Enabling Patient-Centred Care
Matthew I Bellgard, Kathryn Napier, Lee Render, et al.
Annals of Neurology
|
December 7, 2007
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy
Olga L Gurvich, Therese M Tuohy, Michael T Howard, et al.
Stem Cells and Development
|
July 21, 2015
The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow
Laurence de la Kethulle de Ryhove, Eugénie Ansseau, Charlotte Nachtegael, et al.
Molecular Genetics & Genomic Medicine
|
August 7, 2015
Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
Kane Greer, Kayla Mizzi, Emily Rice, et al.
Neuromuscular Disorders : NMD
|
January 19, 2010
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
Linda J Popplewell, Carl Adkin, Virginia Arechavala-Gomeza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2011
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Christophe Pichavant, Annemieke Aartsma-Rus, Paula R Clemens, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 109) with videos related to
Sort By:
Page
of 11
Plos One
|
January 9, 2016
Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies
Zhi Yon Charles Toh, May Thandar Aung-Htut, Gavin Pinniger, et al.
International Journal of Molecular Sciences
|
October 17, 2019
Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
May T Aung-Htut, Craig S McIntosh, Kristin A Ham, et al.
International Journal of Molecular Sciences
|
April 12, 2022
Antisense Oligonucleotide Induction of the hnRNPA1b Isoform Affects Pre-mRNA Splicing of <i>SMN2</i> in SMA Type I Fibroblasts
Jarichad Toosaranont, Sukanya Ruschadaariyachat, Warasinee Mujchariyakul, et al.
Journal of Neuroimmunology
|
September 27, 2012
Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis
Arada Rojana-udomsart, Chalermchai Mitrpant, Ian James, et al.
Studies in Health Technology and Informatics
|
July 27, 2015
A Registry Framework Enabling Patient-Centred Care
Matthew I Bellgard, Kathryn Napier, Lee Render, et al.
Annals of Neurology
|
December 7, 2007
DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy
Olga L Gurvich, Therese M Tuohy, Michael T Howard, et al.
Stem Cells and Development
|
July 21, 2015
The Role of D4Z4-Encoded Proteins in the Osteogenic Differentiation of Mesenchymal Stromal Cells Isolated from Bone Marrow
Laurence de la Kethulle de Ryhove, Eugénie Ansseau, Charlotte Nachtegael, et al.
Molecular Genetics & Genomic Medicine
|
August 7, 2015
Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patient
Kane Greer, Kayla Mizzi, Emily Rice, et al.
Neuromuscular Disorders : NMD
|
January 19, 2010
Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials
Linda J Popplewell, Carl Adkin, Virginia Arechavala-Gomeza, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 7, 2011
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Christophe Pichavant, Annemieke Aartsma-Rus, Paula R Clemens, et al.
Page
of 11